| Literature DB >> 30911282 |
Zhiqiang Pang1, Guoqiang Wang1, Peter Gibson2, Xuewa Guan1, Weijie Zhang3, Ruipeng Zheng1,4, Fang Chen1, Ziyan Wang1, Fang Wang1.
Abstract
Background and Objective: Asthma is a common respiratory disease with a high prevalence and morbidity that can seriously affect quality of life. Microbial colonization of the airway may participate in the pathogenesis of asthma, however the mechanisms involved have not been established. In the present study, we aimed to determine the composition of the microbiota in different asthmatic phenotypes from Northeast China.Entities:
Keywords: asthma; eosinophils; microbiota; neutrophils; phenotype
Mesh:
Year: 2019 PMID: 30911282 PMCID: PMC6428974 DOI: 10.7150/ijms.29433
Source DB: PubMed Journal: Int J Med Sci ISSN: 1449-1907 Impact factor: 3.738
Characteristics of all Subjects
| Phenotypes | Eosinophilic asthma | Non-eosinophilic asthma | Healthy Control |
|---|---|---|---|
| Number of subjects | 10 | 14 | 12 |
| Sex (female/male) | 4/6 | 9/5 | 5/7 |
| Age/years† | 37.30 (30.25, 46.50) | 37.86 (33.00, 46.75) | 41.00 (31.00, 49.75) |
| BMI/(kg·m-2) † | 23.76 (20.18, 26.08) | 24.99 (21.16, 28.03) | 22.93 (22.04, 25.25) |
| Duration of asthma/years† | 3.75 (2.68,5.00) * | 4.10 (2.85, 5.75) * | 0 |
| Serum IgE/(ng·mL-1) † | 202.1 (125.3, 275.5) ** # | 142.2 (62.02, 209.3) | 124.5 (75.89. 133.3) |
| ACQ6† | 0.9520 (0.6700, 1.170) ** | 1.048 (0.7100, 1.290) ** | N/A |
| ICS/(μg·day-1) † ‡ | 570.0 (425.0, 675.0) ** # | 728.6 (600.0, 800.0) ** | 0 (0, 0) |
| FEV1/FVC (%)† | 65.20 (60.25, 70.50) ** | 65.36 (64.00, 69.75) ** | 79.33 (76.48, 83.02) |
| FEV1/FVC (% post) † | 71.60 (64.50, 77.75) | 72.43 (70.00, 78.50) | N/A |
| FEV1 Reversibility (L) † | 0.3880 (0.3375, 0.4225) | 0.4179 (0.3375, 0.4475) | N/A |
| FEV1 Reversibility (%)† | 24.90 (16.50, 31.50) | 30.07 (18.25, 36.00) | N/A |
| White blood cell counts †§ | 7.127 (5.880, 8.482) | 8.299 (5.865, 9.818) | 7.285 (5.888, 8.175) |
| Eosinophil counts†§ | 0.5630 (0.3500, 0.6975) ** ## | 0.1136 (0.0550, 0.1225) | 0.1120 (0.04750, 0.1700) |
| Eosinophil (%)† | 7.990 (59.25, 9.500) ** ## | 1.293 (0.7750, 2.00) | 1.600 (1.000, 2.000) |
| Lymphocyte (%)† | 28.93 (22.32, 35.28) | 25.33 (20.52. 28.97) * | 33.30 (28.00, 39.50) |
| Neutrophil counts†§ | 4.112 (3.320, 5.025) # | 5.689 (3.285, 7.220) * | 4.277 (3.245, 5.042) |
| Neutrophil (%)† | 56.79 (50.82, 59.60) # | 66.64 (62.00, 71.15) * | 58.00 (53.50, 63.75) |
| Score1† | 19.35 (11.50, 21.12) | 9.850 (8.442, 10.26) | N/A |
| Score2† | 24.03 (12.27, 26.85) | 7.214 (5.535, 9.030) | N/A |
† Data are shown as mean (Q1, Q3). ‡ Dosage of inhaled corticosteroid (ICS) was expressed as beclomethasone propionate equivalent dosage. § Unit for cell count is10^9/L. * P < 0.05 vs Healthy control group, **P < 0.01 vs Healthy control group, # P < 0.05 vs Non-eosinophilic asthma group, ##P < 0.01 vs Non-eosinophilic asthma group. BMI, body mass index; ACQ6, asthma control questionnaire 6; FEV1, forced expiratory volume in one second; FVC, forced vital capacity; Both Score1 and Score2 are calculating results of the clustering formula. If Score1 is less than Socre2, clustering the sample as eosinophilic asthma, otherwise as non-eosinophilic asthma.
Figure 1Alpha-diversity analysis of microbiome in eosinophilic asthma (EA) group, non-eosinophilic asthma (NEA) group and healthy control (HC) group. Rarefaction measure of Chao1 index (A1), Observed species index (OBS, B1) and Shannon index (C1) from sequencing matrix in different sequencing depth. Chao1 index statistics (EA vs NEA P<0.01, NEA vs HC P<0.01) (A2), Observed species index statistics (EA vs NEA P<0.01, EA vs HC P<0.05, NEA vs HC P<0.01) (B2) and Shannon index statistics (EA vs NEA P<0.05, EA vs HC P<0.01, NEA vs HC P<0.01) (C2) from matrix sequencing at the depth of 15,750. **, P<0.01 vs HC. #, P<0.05 vs NEA. ##, P<0.01 vs NEA.
Figure 2Beta-diversity analysis of microbiome in eosinophilic asthma (EA) group, non-eosinophilic asthma (NEA) group and healthy control (HC) group. (A) Display of Principal Component Analysis (PCA) of the samples in two-dimension (PC1=43%, PC2=17%). Partial Least Squares Discriminant Analysis (PLS-DA) of all samples under the supervision of (B) the three groups and (C) the different inflammatory phenotypes. (D) Redundancy Analysis (RDA) of all samples and all microbial genera with four potential environment factors (Dose represents the dose of ICS, ACQ6 represents the score of Asthma Control Questionnaire 6 system, Duration of asthma means the duration of asthma history, Spirometry was the ratio of FEV1 and FVC). The genera located at the centre of the RDA are not labelled for their non-obvious associations with the clinical characteristics. EA, NEA and HC are further abbreviated as E, N, H in the panels respectively. The numeric values of the genera in RDA are the sum of RDA1 and RDA2 (%).
Figure 3Taxa distribution of the whole microbiota. Krona projections of the microbiome in different taxonomic level of eosinophilic asthma (EA) group (A), non-eosinophilic asthma (NEA) group (B) and healthy control (HC) group (C). As shown in this figure visually, asthmatics displayed a significant decreased diversity, richness and evenness. The angle of the sector represents the percent of each taxonomic level. It is phylum (p), class (c), order (o), family(f), genus(g) respectively from centre to border respectively. Different symbol in every panel was interpreted as follows. g1: Geobacillus, g2: Granulicatella, g3: Lactococcus, g4: Filifactor, g5: Peptostreptococcus, g6: Catonella, g7: Oribacterium, g8: Megasphaera, g9: Selenomonas, g10: TG5, g11: Leptotrichia, g12: Fusobacterium, g13: Rhodococcus, g14: Corynebacterium, g15: Rothia, g16: Actinomyces, g17: Porphyromonas, g18: Campylobacter, g19: Ochrobactrum, g20: Rhodanobacter, g21: Moraxella, g22: Actinobacillus, g23: Aggregatibacter, g24: Lautropia, g25: Ralstonia, g26: Haemophilus, g27: Atopobium, g28: Lactobacillus.
Figure 4Network analysis and the metabolic prediction of microbiome. The networking pattern of all genera in eosinophilic asthma (EA) group (A), non-eosinophilic asthma (NEA) group (B) and healthy control (HC) group (C) under the criteria of rho > 0.6 and P < 0.05. (Green line represents the positive correlation and red line represents the negative correlation. The size of the point in the network represents the relative abundance of different genera in every groups. All clusters are coloured and displayed with circular layout in the three groups. The red triangle represents a critical genus reported extensively.)
Statistic Content level of the distinct genera between the phenotypes
| Genera | Levels | Fold (EA/NEA/HC) § | |
|---|---|---|---|
| N>E≈H | 0.89/1.2/1.0 | <0.05 | |
| N>E≈H | 0.57/1.3/1.0 | <0.001 | |
| H≈N>E | 0.44/0.96/1.0 | <0.05 | |
| H≈N>E | 0.067/0.89/1.0 | <0.05 | |
| E>N≈H | 16/1.0/1.0 | <0.001 | |
| E>H>N | 1.5/0.091/1.0 | <0.01 |
† P values were calculated statistically and followed by False Discovery Rate (FDR) for comparison between the phenotypes. § The changed fold values of distinct phyla were the ratios of the logarithmic transformation on the respective OTU ratios.